NCT06721520 2026-02-25
EMPTY
The Cleveland Clinic
Phase 2/3 Recruiting
Clinical Trials
5 trialsNCT04965311 2025-05-13
Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy
OHSU Knight Cancer Institute
Phase 2 Terminated
NCT02965976 2023-02-16
Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT01822210 2018-03-09
Botulinum Toxin for Stomach Cancer Treatment
St. Olavs Hospital
Phase 2 Completed
NCT01589471 2018-02-12
The Value of Botox-A for Management of Low Anterior Resection Syndrome
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2 Completed